Form 8-K PULSE BIOSCIENCES, INC. For: Sep 14
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Pulse Biosciences sets up $85M at-the-market stock offering
September 15, 2026 4:46 PM EDTPulse Biosciences, Inc. (NASDAQ: PLSE) entered into an equity distribution agreement with Mizuho Securities USA LLC on September 15, 2026, allowing the company to sell up to $85,000,000 in common stock through at-the-market offerings on the Nasdaq Capital Market.
Under the agreement, Mizuho... More
